The Secretary of Health of the United States, Alex Azar, claimed that Americans could begin receiving the Pfizer / BioNTech COVID-19 vaccine on Monday.
The US Food and Drug Administration (FDA) accelerated work to finalize approval of the vaccine after an advisory panel voted 17 to 4 in favor of granting emergency use. President Donald Trump has urged authorities to move quickly.
Pharmaceutical companies showed a 95% effectiveness rate in defending against coronavirus in their phase 3 trial, showing no serious side effects.
Modern It also successfully completed its Phase 3 trial and uses the same mRNA technology as Pfizer. The FDA will discuss its application on Thursday, December 17.
.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
